Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Basic Description
| Synonyms | nicotinic acid | niacin | 59-67-6 | Pyridine-3-carboxylic acid | 3-pyridinecarboxylic acid | vitamin B3 | 3-Carboxypyridine | wampocap | Niaspan | Acidum nicotinicum | nicolar | Apelagrin | Pellagrin | Akotin | Daskil | Efacin | Pelonin | Linic | nicamin | nicobid | nicocap | Enduracin | Nicodelmin |
|---|---|
| Specifications & Purity | Moligand™, ≥99.5%(HPLC) |
| Biochemical and Physiological Mechanisms | Nicotinic acid or Niacin regulates lipid metabolism by reducing low density lipoprotein (LDL), increasing high-density lipoprotein (HDL) and by inhibiting the progression of atherosclerosis and coronary artery lesions. Niacin deficiency leads to pellagra. |
| Storage Temp | Protected from light |
| Shipped In | Normal |
| Grade | Moligand™ |
| Product Description | Nicotinic acid, also referred as Niacin or vitamin B 3 , is a water soluble vitamin. It is present in vitamin-enriched bread, liver, meat, fish, poultry, potatoes, green vegetables, peanuts and cereals. Application Nicotinic acid has been used as a standard in NAD + precursor rescue experiments. It has also been used as a vitamin supplement in various culture media such as complete medium (CM) and synthetic medium. Other Notes Coenzyme and Cofactors, vol 2: Pyridine Nucleotide Coenzymes |
Associated Targets(Human)
HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (14 Activities)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CA2 Tclin Carbonic anhydrase II (17698 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HMGCR Tclin HMG-CoA reductase (2475 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
INSR Tclin Insulin receptor (5558 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PGR Tclin Progesterone receptor (8562 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AR Tclin Androgen Receptor (11781 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
TYR Tclin Tyrosinase (717 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MAOA Tclin Monoamine oxidase A (11911 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACHE Tclin Acetylcholinesterase (18204 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH2 Tclin Histamine H2 receptor (5428 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CALCR Tclin Calcitonin receptor (2215 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A4 Tclin Serotonin transporter (12625 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH1 Tclin Histamine H1 receptor (7573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRM1 Tclin Mu opioid receptor (19785 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRD1 Tclin Delta opioid receptor (15096 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GCGR Tclin Glucagon receptor (2563 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
XDH Tclin Xanthine dehydrogenase (1038 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A3 Tclin Dopamine transporter (10535 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mc4r Melanocortin receptor 4 (1205 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Ltc4s Leukotriene C4 synthase (1 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Sigmar1 Sigma opioid receptor (160 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cckar Cholecystokinin A receptor (90 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Ntsr1 Neurotensin receptor 1 (48 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Pde4d Phosphodiesterase 4D (4 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Bdkrb1 Bradykinin B1 receptor (77 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Nos2 Nitric oxide synthase, inducible (3573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mapk1 MAP kinase ERK2 (650 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Hdac6 Histone deacetylase 6 (222 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mmp9 Matrix metalloproteinase 9 (38 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Hcar2 Hydroxycarboxylic acid receptor 2 (55 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Pseudomonas aeruginosa (123386 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Klebsiella pneumoniae (43867 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Staphylococcus aureus (210822 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acinetobacter baumannii (41033 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Escherichia coli (133304 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Aspergillus flavus (8875 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mycobacterium tuberculosis variant bovis (1746 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Plasmodium falciparum (966862 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cryptococcus neoformans (21258 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Candida albicans (78123 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Leishmania donovani (89745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Trypanosoma cruzi (99888 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Meloidogyne incognita (862 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Canis familiaris (36305 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus (284745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rattus norvegicus (775804 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Trypanosoma brucei rhodesiense (7991 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
L1210 (27553 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
RAW264.7 (28094 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HT-22 (3261 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Fusarium verticillioides (912 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
norA Quinolone resistance protein norA (2171 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
rep Replicase polyprotein 1ab (378 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
pfk 6-phospho-1-fructokinase (7870 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Plasma (328 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Intestine (514 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cat Catalase (15 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Slc22a5 Solute carrier family 22 member 5 (44 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
clpP ATP-dependent Clp protease proteolytic subunit (245 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cenchrus americanus (77 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Glra2 Glycine receptor (1745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SARS-CoV-2 (38078 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Names and Identifiers
| IUPAC Name | pyridine-3-carboxylic acid |
|---|---|
| INCHI | InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) |
| InChi Key | PVNIIMVLHYAWGP-UHFFFAOYSA-N |
| Canonical SMILES | C1=CC(=CN=C1)C(=O)O |
| Isomeric SMILES | C1=CC(=CN=C1)C(=O)O |
| RTECS | QT0525000 |
| Alternate CAS | 59-67-6,99148-57-9 (tosylate) |
| PubChem CID | 938 |
| NSC Number | 169454 |
| MeSH Entry Terms | 3 Pyridinecarboxylic Acid;3-Pyridinecarboxylic Acid;Aluminum Salt, Niacin;Enduracin;Hydrochloride, Niacin;Induracin;Lithium Nicotinate;Niacin;Niacin Aluminum Salt;Niacin Ammonium Salt;Niacin Calcium Salt;Niacin Cobalt (2+) Salt;Niacin Copper (2+) Salt;Nia |
| Molecular Weight | 123.11 |
| Beilstein | 109591 |
Certificates
Certificate of Analysis(COA)
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 E2308216 | Certificate of Analysis | May 23, 2023 | N433033 |
| E2308226 | Certificate of Analysis | May 22, 2023 | N433033 |
| E2308240 | Certificate of Analysis | May 22, 2023 | N433033 |
| F2317359 | Certificate of Analysis | Mar 31, 2023 | N433033 |
| F2317360 | Certificate of Analysis | Mar 31, 2023 | N433033 |
| F2317386 | Certificate of Analysis | Mar 31, 2023 | N433033 |
| F2317399 | Certificate of Analysis | Mar 31, 2023 | N433033 |
| F2317467 | Certificate of Analysis | Mar 31, 2023 | N433033 |
Chemical and Physical Properties
| Solubility | water: 0.1g/10 mL, clear, colorless |
|---|---|
| Sensitivity | Light sensitive |
| Flash Point(°C) | 193°C |
| Melt Point(°C) | 238°C |
Safety and Hazards(GHS)
| Pictogram(s) | GHS07 |
|---|---|
| Signal | Warning |
| Hazard Statements | H319:Causes serious eye irritation H412:Harmful to aquatic life with long lasting effects |
| Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P501:Dispose of contents/container to ... P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. |
| RTECS | QT0525000 |
| Merck Index | 6525 |
Related Documents
Citations of This Product
| 1. Yangyang Sun, Zhuzhu Tang, Yanjun Li, Yongkang Song, Hualei Wang, Dongzhi Wei, Shengli Yang. (2024) Identification and evolution of non-traditional nitrilase from Spirosoma linguale DSM 74 with high hydration activity. BIOORGANIC CHEMISTRY, 143 (107055). [PMID:38185008] |
| 2. Zhi Chen, Zhaohe Dong, Xin Ju, Lishi Yan, Liangzhi Li, Donzhi Wei. (2023) Screening of a novel and thermostable nicotinate dehydrogenase-producing strain Bacillus paramycoides for efficient synthesis of 6-hydroxynicotinic acid. BIOCATALYSIS AND BIOTRANSFORMATION, [PMID:22383884] |
| 3. Fangfang Li, Yueyue Hu, Yong Cheng, Ying-Hua Zhou. (2024) Design of composite based on UiO-66 and ionic liquid for the CO2 conversion into cyclocarbonate. MICROPOROUS AND MESOPOROUS MATERIALS, 365 (20): (112909). [PMID:20723760] |
| 4. Zhipeng Wang, Tingting Ma, Junkai Wang, Shaorun Zhu, Mei Zhang, Min Guo. (2023) Surface passivation for efficient and stable perovskite solar cells in ambient air: The structural effect of amine molecules. CERAMICS INTERNATIONAL, [PMID:] |
| 5. Xinyu Shao, Lulu Cao, Lixia Lu. (2024) Ultrasensitive detection of glucose oxidase and alkaline phosphatase in milk based on valence regulated upconversion nanoprobes. FOOD CHEMISTRY, 432 (137212). [PMID:37634343] |
| 6. Yu Yangjian, Liu Peng, Wang Fazhou, Hu Chuanlin. (2023) Preparation of Hydrophobic Fly Ash by Surface Modification and Oil-water Separation Devices. JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION, 38 (3): (695-700). [PMID:] |
| 7. Xiao-Dong Cheng, Zheng Zhang, Yun-Ping Li. (2023) A facile approach to undecylenic acid-functionalized stationary phases for per aqueous liquid chromatography. ANALYTICA CHIMICA ACTA, 1265 (341337). [PMID:37230580] |
| 8. Chao-ping He, Wen-juan Quan, Ya-ling Zeng, Hong-yan Zhou, Pei-dong You, Zhen-xian Li, Ya-mei Li, Li-mei Lin, Bin Liu, Duan-fang Liao, Qin-hui Tuo. (2023) Construction of nicotinic acid curcumin nanoparticles and its Anti-atherosclerosis effect via PCSK9/LDL-R, ABCA1/Caveolin-1/LXR pathway. MATERIALS & DESIGN, 229 (111931). [PMID:] |
| 9. Zhiyong Zheng, Yuehua Deng, Weining Xie, Sirui Chen, Xiaoxiao Liang, Shiyuan Liu, Yanbin Jiang, Huaiyu Yang. (2023) Co-Former Screening Method for Multicomponent Crystals Based on Partial Least Squares Regression: A Case Study of Ciprofloxacin. CRYSTAL GROWTH & DESIGN, 23 (5): (3244–3257). [PMID:] |
| 10. Hengye Li, Xingwei Han, Lin Zhang, Wenjie Yu, Wenwen Bie, Meijie Wei, Zhongxia Wang, Fenying Kong, Wei Wang. (2023) Sulfonated polyhedral oligomeric silsesquioxane-cyclodextrin hybrid polymers for efficient removal of micropollutants from water. CARBOHYDRATE POLYMERS, 312 (120832). [PMID:37059548] |
| 11. Wenlong Wan, Jie Xu, Jiayuan Shi, Xin Zhang, Anran Wang, Xiaojing Dong, Shuyan Miao. (2023) The interaction of dietary niacin and lipid affects the growth, antioxidant capacity and lipid metabolism of male Eriocheir sinensis. Aquaculture Reports, 30 (101541). [PMID:] |
| 12. Hengye Li, Xingwei Han, Wenjie Yu, Lin Zhang, Wenwen Bie, Meijie Wei, Zhongxia Wang, Fenying Kong, Wei Wang. (2023) Synthesis of porous dimethoxypillar[5]arene knitted β-cyclodextrin copolymers for efficient adsorption of organic micropollutants. CARBOHYDRATE POLYMERS, 310 (120719). [PMID:36925245] |
| 13. Xue-Jiao Liu, Bao-Di Ma, Xiao-Mei Wu, Yi Xu. (2023) Highly Efficient Biosynthesis of Nicotinic Acid by Immobilized Whole Cells of E. coli Expressing Nitrilase in Semi-Continuous Packed-Bed Bioreactor. Catalysts, 13 (2): (371). [PMID:] |
| 14. Hongwei Ren, Yize Liu, Ruoyao Zhang, Tengda Zhao, Jing Han, Zhiyang Zheng, Erhong Duan. (2023) Investigation of the CO2 capture behavior in multiple-site natural deep eutectic solvents. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, 172 (136). [PMID:] |
| 15. Huifang Wu, Mengqi Xu, Yubing Chen, Haoliang Zhang, Yongjun Shen, Yanfeng Tang. (2022) A Highly Sensitive and Selective Nano-Fluorescent Probe for Ratiometric and Visual Detection of Oxytetracycline Benefiting from Dual Roles of Nitrogen-Doped Carbon Dots. Nanomaterials, 12 (23): (4306). [PMID:36500929] |
| 16. Zhiqin Ding, Mengdie Cai, Weimin Gan, Ping Yuan, Lijun Wei, Xianglei Cheng. (2023) Studies on a novel method for the determination of nitrosamines in food by HPLC-UV-FLD coupling with terbium-doped carbon dots. FOOD CHEMISTRY, 405 (134894). [PMID:] |
| 17. Lin Yuan, Lei Jiang, Ze Liu, Yingying Xiang, Fei Song, Yujiao Tu. (2023) Selective and sensitive simultaneous detection of tartrazine and Hg2+ based on N-doped yellow-green fluorescent carbon dots. DYES AND PIGMENTS, 209 (110893). [PMID:] |
| 18. Jinsong Wang, Farzad Seidi, Yang Huang, Huining Xiao. (2022) Smart lignin-based polyurethane conjugated with corrosion inhibitor as bio-based anticorrosive sublayer coating. INDUSTRIAL CROPS AND PRODUCTS, 188 (115719). [PMID:] |
| 19. Yingying Xiang, Yujiao Tu, Lei Jiang, Lin Yuan, Ze Liu, Qiang Xie, Xuequan Xiong, Fei Song. (2022) Orange fluorescent dual-mode nanoprobe for selective and sensitive detection of amaranth based on S,N-Doped carbon dots. DYES AND PIGMENTS, 205 (110533). [PMID:] |
| 20. Shan Yuan, Miaomiao Jin, Chao Xu, Wencheng Yin, Mingsha Zhao, Mo Xian, Wei Liu. (2022) Self-sufficient whole-cell biocatalysis for 3-(aminomethyl) pyridine synthesis. BIOCHEMICAL ENGINEERING JOURNAL, 183 (108457). [PMID:] |
| 21. Xiang Yingying, Song Fei, Jiang Lei, Liu Ze, Tu Yujiao. (2022) Novel Fluorescent Nano Carbon Quantum Dots Derived From Lactarius Hatsudake for High Selective Vitamin B12 Detection. JOURNAL OF AOAC INTERNATIONAL, 105 (5): (1350-1359). [PMID:35244160] |
| 22. Haizhi Zhang, Hongyuan Wu, Xinguang Qin, Ying Shen, Xinlin Wei, Gang Liu. (2022) Metalloporphyrin and gold nanoparticles modified hollow zeolite imidazole Framework-8 with excellent peroxidase like activity for quick colorimetric determination of choline in infant formula milk powder. FOOD CHEMISTRY, 384 (132552). [PMID:35231712] |
| 23. Zhijun Zhao, Jubao Gao, Mingsheng Luo, Xinyue Liu, Yongsheng Zhao, Weiyang Fei. (2022) Molecular Simulation and Experimental Study on Low-Viscosity Ionic Liquids for High-Efficient Capturing of CO2. ENERGY & FUELS, 36 (3): (1604–1613). [PMID:] |
| 24. Wang Qiaoying, Cai Jiali, Xu Zihan, Huang Shihui, Zhou Ruiping, Wang Zhiyong. (2022) Albumin-based Theranostic Nanosystem for Drug Controlled Release and Magnetic Resonance Imaging Guided Therapy. Journal of Bionic Engineering, 19 (1): (188-196). [PMID:] |
| 25. Mengqi Huang, Changlun Tong. (2022) Silicon nanoparticles / gold nanoparticles composite as a fluorescence probe for sensitive and selective detection of Co2+ and vitamin B12 based on the selective aggregation and inner filter effect. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 268 (120706). [PMID:34915228] |
| 26. Li Qiaofeng, Lan Taijin, He Songhua, Chen Weiwei, Li Xiaolan, Zhang Weiquan, Liu Ying, Zhang Qiuping, Chen Xin, Han Yaoyao, Su Zhiheng, Zhu Dan, Guo Hongwei. (2021) A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model. Chinese Medicine, 16 (1): (1-21). [PMID:34627325] |
| 27. Xiao-Dong Cheng,Yan-Hong Hao,Xi-Tian Peng,Bi-Feng Yuan,Zhi-Guo Shi,Yu-Qi Feng. (2015-05-13) Preparation and chromatographic evaluation of zwitterionic stationary phases with controllable ratio of positively and negatively charged groups.. Talanta, 141 (8-14). [PMID:25966373] |
References
| 1. Richman JG, Kanemitsu-Parks M, Gaidarov I, Cameron JS, Griffin P, Zheng H, Guerra NC, Cham L, Maciejewski-Lenoir D, Behan DP et al.. (2007) Nicotinic acid receptor agonists differentially activate downstream effectors.. J Biol Chem, 282 (25): (18028-36). [PMID:17452318] |
| 2. Jung JK, Johnson BR, Duong T, Decaire M, Uy J, Gharbaoui T, Boatman PD, Sage CR, Chen R, Richman JG et al.. (2007) Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.. J Med Chem, 50 (7): (1445-8). [PMID:17358052] |
| 3. Shen HC, Szymonifka MJ, Kharbanda D, Deng Q, Carballo-Jane E, Wu KK, Wu TJ, Cheng K, Ren N, Cai TQ et al.. (2007) Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.. Bioorg Med Chem Lett, 17 (24): (6723-8). [PMID:18029181] |
| 4. Skinner PJ, Webb PJ, Sage CR, Dang TH, Pride CC, Chen R, Tamura SY, Richman JG, Connolly DT, Semple G. (2009) 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.. Bioorg Med Chem Lett, 19 (15): (4207-9). [PMID:19524438] |
| 5. Bach P, Antonsson T, Bylund R, Björkman JA, Österlund K, Giordanetto F, van Giezen JJ, Andersen SM, Zachrisson H, Zetterberg F. (2013) Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283.. J Med Chem, 56 (17): (7015-24). [PMID:23899349] |
| 6. J E Mrochek,R L Jolley,D S Young,W J Turner. (1976-11-01) Metabolic response of humans to ingestion of nicotinic acid and nicotinamide.. Clinical chemistry, 22 ((11)): (1821-1827). [PMID:135660] |
| 7. M R Stratford,M F Dennis,P Hoskin,H Phillips,R J Hodgkiss,A Rojas. (1996-07-01) Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.. British journal of cancer, 74 ((1)): (16-21). [PMID:8679452] |
| 8. Nicholas B Pike. (2005-12-03) Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.. The Journal of clinical investigation, 115 ((12)): (3400-3403). [PMID:16322787] |
| 9. Tawfik Gharbaoui,Philip J Skinner,Young-Jun Shin,Claudia Averbuj,Jae-Kyu Jung,Benjamin R Johnson,Tracy Duong,Marc Decaire,Jane Uy,Martin C Cherrier,Peter J Webb,Susan Y Tamura,Ning Zou,Nathalie Rodriguez,P Douglas Boatman,Carleton R Sage,Andrew Lindstrom,Jerry Xu,Thomas O Schrader,Brian M Smith,Ruoping Chen,Jeremy G Richman,Daniel T Connolly,Steven L Colletti,James R Tata,Graeme Semple. (2007-06-26) Agonist lead identification for the high affinity niacin receptor GPR109a.. Bioorganic & medicinal chemistry letters, 17 ((17)): (4914-4919). [PMID:17588745] |
| 10. Katrina L Bogan,Charles Brenner. (2008-04-24) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.. Annual review of nutrition, 28 (115-130). [PMID:18429699] |
| 11. Subharekha Raghavan,G Scott Tria,Hong C Shen,Fa-Xiang Ding,Andrew K Taggart,Ning Ren,Larrisa C Wilsie,Mihajlo L Krsmanovic,Tom G Holt,Michael S Wolff,M Gerard Waters,Milton L Hammond,James R Tata,Steven L Colletti. (2008-05-15) Tetrahydro anthranilic acid as a surrogate for anthranilic acid: application to the discovery of potent niacin receptor agonists.. Bioorganic & medicinal chemistry letters, 18 ((11)): (3163-3167). [PMID:18477506] |
| 12. Vaijinath S Kamanna,Anthony Vo,Moti L Kashyap. (2008-06-04) Nicotinic acid: recent developments.. Current opinion in cardiology, 23 ((4)): (393-398). [PMID:18520725] |
| 13. H E Bays,D J Rader. (2008-12-05) Does nicotinic acid (niacin) lower blood pressure?. International journal of clinical practice, 63 ((1)): (151-159). [PMID:19054161] |
| 14. Jason E Imbriglio,Sookhee Chang,Rui Liang,Subharekha Raghavan,Darby Schmidt,Abby Smenton,Scott Tria,Thomas O Schrader,Jae-Kyu Jung,Craig Esser,Andrew K P Taggart,Kang Cheng,Ester Carballo-Jane,M Gerard Waters,James R Tata,Steven L Colletti. (2009-03-25) GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.. Bioorganic & medicinal chemistry letters, 19 ((8)): (2121-2124). [PMID:19307116] |
| 15. Janet E Digby,Justin M S Lee,Robin P Choudhury. (2009-06-06) Nicotinic acid and the prevention of coronary artery disease.. Current opinion in lipidology, 20 ((4)): (321-326). [PMID:19494772] |
| 16. Paul Martres. (2009-06-13) HM74a agonists: will they be the new generation of nicotinic acid?. Current topics in medicinal chemistry, 9 ((5)): (428-435). [PMID:19519459] |
| 17. Caroline M Perry. (2009-08-15) Extended-release niacin (nicotinic acid)/laropiprant.. Drugs, 69 ((12)): (1665-1679). [PMID:19678716] |
| 18. Heinz Drexel. (2009-08-18) Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?. Fundamental & clinical pharmacology, 23 ((6)): (687-692). [PMID:19682084] |
| 19. Takeki Uehara, Atsushi Ono, Toshiyuki Maruyama, Ikuo Kato, Hiroshi Yamada, Yasuo Ohno, Tetsuro Urushidani. (2009-12-31) The Japanese toxicogenomics project: application of toxicogenomics.. Molecular nutrition & food research, 54 ((2)): (218-227). [PMID:20041446] |
| 20. Darby Schmidt,Abigail Smenton,Subharekha Raghavan,Hong Shen,Fa-Xiang Ding,Ester Carballo-Jane,Silvi Luell,Tanya Ciecko,Tom G Holt,Michael Wolff,Andrew Taggart,Larissa Wilsie,Mihajlo Krsmanovic,Ning Ren,Daniel Blom,Kang Cheng,Peggy E McCann,M Gerard Waters,James Tata,Steven Colletti. (2010-05-07) Anthranilic acid replacements in a niacin receptor agonist.. Bioorganic & medicinal chemistry letters, 20 ((11)): (3426-3430). [PMID:20444602] |
| 21. Hans F N Kvitvang,Trygve Andreassen,Tomas Adam,Silas G Villas-Bôas,Per Bruheim. (2011-03-11) Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids.. Analytical chemistry, 83 ((7)): (2705-2711). [PMID:21388201] |
| 22. Minjun Chen,Vikrant Vijay,Qiang Shi,Zhichao Liu,Hong Fang,Weida Tong. (2011-06-01) FDA-approved drug labeling for the study of drug-induced liver injury.. Drug discovery today, 16 ((15-16)): (697-703). [PMID:21624500] |
| 23. Rachael Hartman,Taylor Defelice,Julia Tzu,Shane Meehan,Miguel Sanchez. (2011-10-28) Acanthosis nigricans in the setting of niacin therapy.. Dermatology online journal, 17 ((10)): (11-11). [PMID:22031637] |
| 24. Rahul Yadav,See Kwok,Basil J Ammori,Basil Issa,Handrean Soran. (2011-12-03) Safety and tolerability of extended-release niacin with laropiprant.. Expert opinion on drug safety, 11 ((1)): (151-159). [PMID:22133050] |
| 25. Xianhai Huang,Jing Su,Ashwin U Rao,Haiqun Tang,Wei Zhou,Xiaohong Zhu,Xiao Chen,Zhidan Liu,Ying Huang,Sylvia Degrado,Dong Xiao,Jun Qin,Robert Aslanian,Brian A McKittrick,Scott Greenfeder,Margaret van Heek,Madhu Chintala,Anandan Palani. (2012-01-03) SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist.. Bioorganic & medicinal chemistry letters, 22 ((2)): (854-858). [PMID:22209457] |
| 26. Andrew P Dunatchik,Matthew K Ito,Carlos A Dujovne. (2012-03-06) A systematic review on evidence of the effectiveness and\xa0safety of a wax-matrix niacin formulation.. Journal of clinical lipidology, 6 ((2)): (121-131). [PMID:22385545] |
| 27. Tai-Heng Chen,Clement Mtika. (2012-11-02) The peeling dermatitis with a peculiar demarcation.. The American journal of the medical sciences, 346 ((5)): (421-421). [PMID:23114198] |
| 28. Robert Ringseis,Susann Rosenbaum,Denise K Gessner,Lea Herges,Johanna F Kubens,Frank-Christoph Mooren,Karsten Krüger,Klaus Eder. (2012-12-21) Supplementing obese Zucker rats with niacin induces the transition of glycolytic to oxidative skeletal muscle fibers.. The Journal of nutrition, 143 ((2)): (125-131). [PMID:23256146] |
| 29. U Julius,S Fischer. (2013-01-30) Nicotinic acid as a lipid-modifying drug--a review.. Atherosclerosis. Supplements, 14 ((1)): (7-13). [PMID:23357134] |
| 30. Wanda C Lakey,Nicole Greyshock,John R Guyton. (2013-02-19) Adverse reactions of Achilles tendon xanthomas in three hypercholesterolemic patients after treatment intensification with niacin and bile acid sequestrants.. Journal of clinical lipidology, 7 ((2)): (178-181). [PMID:23415439] |
| 31. Angela Pirillo,Giuseppe Danilo Norata,Alberico Luigi Catapano. (2013-02-23) High-density lipoprotein subfractions--what the clinicians need to know.. Cardiology, 124 ((2)): (116-125). [PMID:23428644] |
| 32. . (2013-03-08) Drugs for hypertriglyceridemia.. The Medical letter on drugs and therapeutics, 55 ((1411)): (17-19). [PMID:23467119] |
| 33. Tom Noff,Jerald Insel. (2013-04-06) Energy drinks and the unwanted buzz: a case report.. Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society, 13 ((4)): (28-29). [PMID:23556369] |
| 34. Baiba K Gillard,Joe L Raya,Raul Ruiz-Esponda,Dinakar Iyer,Ivonne Coraza,Ashok Balasubramanyam,Henry J Pownall. (2013-05-04) Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.. Arteriosclerosis, thrombosis, and vascular biology, 33 ((7)): (1714-1721). [PMID:23640486] |
| 35. N Nakajima,M Ueda,N Higashi,Y Katayama. (2013-05-07) Erythromelalgia associated with Clitocybe acromelalga intoxication.. Clinical toxicology (Philadelphia, Pa.), 51 ((5)): (451-454). [PMID:23641936] |
| 36. Da Li,Yan-Jie Tian,Jing Guo,Wu-Ping Sun,Yong-Zhi Lun,Ming Guo,Ning Luo,Yu Cao,Ji-Min Cao,Xiao-Jie Gong,Shi-Sheng Zhou. (2013-06-19) Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.. The British journal of nutrition, 110 ((12)): (2156-2164). [PMID:23768418] |
| 37. Ibragim Gaidarov,Xiaohua Chen,Todd Anthony,Dominique Maciejewski-Lenoir,Chen Liaw,David J Unett. (2013-06-19) Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.. Cellular signalling, 25 ((10)): (2003-2016). [PMID:23770183] |
| 38. Kambiz Zandi-Nejad,Ayumi Takakura,Mollie Jurewicz,Anil K Chandraker,Stefan Offermanns,David Mount,Reza Abdi. (2013-07-25) The role of HCA2 (GPR109A) in regulating macrophage function.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 27 ((11)): (4366-4374). [PMID:23882124] |
| 39. Pieter-Jan De Kam,Wen-Lin Luo,Larissa Wenning,Lisa Ratcliffe,Christine McCrary Sisk,Jane Royalty,Waldemar Radziszewski,John A Wagner,Eseng Lai. (2013-11-12) The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.. Platelets, 25 ((7)): (480-487). [PMID:24206527] |
| 40. Kimberly A Gudzune,Anne K Monroe,Ritu Sharma,Padmini D Ranasinghe,Yohalakshmi Chelladurai,Karen A Robinson. (2014-02-12) Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.. Annals of internal medicine, 160 ((7)): (468-476). [PMID:24514899] |
| 41. Hans-Michael Wolff,Irsan,Kalliopi Dodou. (2014-03-07) Investigations on the viscoelastic performance of pressure sensitive adhesives in drug-in-adhesive type transdermal films.. Pharmaceutical research, 31 ((8)): (2186-2202). [PMID:24599801] |
| 42. Alberto Zambon,Xue-Qiao Zhao,B Greg Brown,John D Brunzell. (2014-03-20) Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease.. The American journal of cardiology, 113 ((9)): (1494-1498). [PMID:24641964] |
| 43. Maria Angela Guzzardi,Leanne Hodson,Letizia Guiducci,Elena Sanguinetti,Pietro Di Cecco,Tiziana Liistro,Cristina Vassalle,Silvia Pardini,Lucia Giorgetti,Piero A Salvadori,Silvia Burchielli,Patricia Iozzo. (2014-06-26) Independent effects of circulating glucose, insulin and NEFA on cardiac triacylglycerol accumulation and myocardial insulin resistance in a swine model.. Diabetologia, 57 ((9)): (1937-1946). [PMID:24962669] |
| 44. Sofia Tapani,Joachim Almquist,Jacob Leander,Christine Ahlström,Lambertus A Peletier,Mats Jirstrand,Johan Gabrielsson. (2014-07-06) Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.. Journal of pharmaceutical sciences, 103 ((8)): (2571-2584). [PMID:24986056] |
| 45. Donald M Lloyd-Jones. (2014-07-12) Niacin and HDL cholesterol--time to face facts.. The New England journal of medicine, 371 ((3)): (271-273). [PMID:25014692] |
| 46. Michael McCarthy. (2014-07-25) Niacin fails to reduce vascular events in large randomised trial.. BMJ (Clinical research ed.), 349 (g4774-g4774). [PMID:25055803] |
| 47. Mack Moyo,Stephen O Amoo,Adeyemi O Aremu,Jiří Gruz,Michaela Subrtová,Karel Doležal,Johannes Van Staden. (2014-09-16) Plant regeneration and biochemical accumulation of hydroxybenzoic and hydroxycinnamic acid derivatives in Hypoxis hemerocallidea organ and callus cultures.. Plant science : an international journal of experimental plant biology, 227 (157-164). [PMID:25219317] |
| 48. Anja Veronovski,Gabrijela Tkalec,Željko Knez,Zoran Novak. (2014-09-27) Characterisation of biodegradable pectin aerogels and their potential use as drug carriers.. Carbohydrate polymers, 113 (272-278). [PMID:25256485] |
| 49. K Maráková,J Piestanský,E Havránek,P Mikus. (2014-10-03) Simultaneous analysis of vitamins B in pharmaceuticals and dietary supplements by capillary electrophoresis hyphenated with triple quadrupole mass spectrometry.. Die Pharmazie, 69 ((9)): (663-668). [PMID:25272936] |
| 50. Martin J Landray,Richard Haynes,Jane Armitage. (2014-11-13) Niacin for reduction of cardiovascular risk.. The New England journal of medicine, 371 ((20)): (1943-1944). [PMID:25390748] |
| 51. Christopher M Rembold. (2014-11-13) Niacin for reduction of cardiovascular risk.. The New England journal of medicine, 371 ((20)): (1940-1941). [PMID:25390749] |
| 52. Inge A M van den Oever,Michael T Nurmohamed,Willem F Lems. (2014-11-13) Niacin for reduction of cardiovascular risk.. The New England journal of medicine, 371 ((20)): (1942-1942). [PMID:25390752] |
| 53. Amit V Khera,Arman Qamar,Muredach P Reilly,Richard L Dunbar,Daniel J Rader. (2014-11-30) Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 levels in patients with dyslipidemia.. The American journal of cardiology, 115 ((2)): (178-182). [PMID:25432415] |
| 54. Vladimir Tolstikov,Alexander Nikolayev,Sucai Dong,Genshi Zhao,Ming-Shang Kuo. (2014-12-09) Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.. PloS one, 9 ((12)): (e114019-e114019). [PMID:25486521] |
| 55. Won Seok Yang,Hyun Woo Kim,Joo Mi Lee,Nam Jeong Han,Mee Jeong Lee,Su-Kil Park. (2015-01-04) 1,25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells.. Molecular pharmacology, 87 ((3)): (533-542). [PMID:25556238] |
| 56. Umi Fahmida,Otte Santika,Risatianti Kolopaking,Elaine Ferguson. (2015-02-03) Complementary feeding recommendations based on locally available foods in Indonesia.. Food and nutrition bulletin, 35 ((4 Suppl)): (S174-S179). [PMID:25639135] |
| 57. Daisuke Yasuda,Yuki Imura,Satoshi Ishii,Takao Shimizu,Motonao Nakamura. (2015-02-19) The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 29 ((6)): (2412-2422). [PMID:25690651] |
| 58. Rohini Sidhu,Hui Jiang,Nicole Y Farhat,Nuria Carrillo-Carrasco,Myra Woolery,Elizabeth Ottinger,Forbes D Porter,Jean E Schaffer,Daniel S Ory,Xuntian Jiang. (2015-04-14) A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.. Journal of lipid research, 56 ((6)): (1222-1233). [PMID:25866316] |
| 59. Mónica Acevedo,Paola Varleta,Verónica Kramer,Giovanna Valentino,Teresa Quiroga,Carolina Prieto,Jacqueline Para. (2015-06-20) Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor.. International journal of endocrinology, 2015 (934681-934681). [PMID:26089902] |
| 60. Shuai Yang,Xitao Li,Nasui Wang,Guoshu Yin,Shuhua Ma,Yucai Fu,Chiju Wei,Yongsong Chen,Wencan Xu. (2015-06-28) GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.. Annals of clinical and laboratory science, 45 ((3)): (315-322). [PMID:26116596] |
| 61. Victoria G Pederick,Bart A Eijkelkamp,Stephanie L Begg,Miranda P Ween,Lauren J McAllister,James C Paton,Christopher A McDevitt. (2015-08-21) ZnuA and zinc homeostasis in Pseudomonas aeruginosa.. Scientific reports, 5 (13139-13139). [PMID:26290475] |
| 62. D L Cooper,J A Carmical,P C Panus,S Harirforoosh. (2015-11-05) Formulation and in vitro evaluation of niacin-loaded nanoparticles to reduce prostaglandin mediated vasodilatory flushing.. European review for medical and pharmacological sciences, 19 ((20)): (3977-3988). [PMID:26531288] |
| 63. Igor Shats,Jason G Williams,Juan Liu,Mikhail V Makarov,Xiaoyue Wu,Fred B Lih,Leesa J Deterding,Chaemin Lim,Xiaojiang Xu,Thomas A Randall,Ethan Lee,Wenling Li,Wei Fan,Jian-Liang Li,Marina Sokolsky,Alexander V Kabanov,Leping Li,Marie E Migaud,Jason W Locasale,Xiaoling Li. (2020-03-05) Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway.. Cell metabolism, 31 ((3)): (564-579). [PMID:32130883] |
| 64. Amanda Rennick,Rabih Kalakeche,Lindsey Seel,Brian Shepler. (2013-03-26) Nicotinic acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients.. Pharmacotherapy, 33 ((6)): (683-690). [PMID:23526664] |
| 65. Amit V Khera,Parin J Patel,Muredach P Reilly,Daniel J Rader. (2013-08-13) The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.. Journal of the American College of Cardiology, 62 ((20)): (1909-1910). [PMID:23933538] |
| 66. J Sirc,J Hrib,M Vetrik,R Hobzova,A Zak,B Stankova,O Slanar,R Hromadka,V Sandrikova,J Michalek. (2015-10-09) The use of a hydrogel matrix for controlled delivery of niacin to the gastrointestinal tract for treatment of hyperlipidemia.. Physiological research, 64 Suppl 1 (S51-S60). [PMID:26447595] |
| 67. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong. (2011-12-24) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).. PLoS computational biology, 7 ((12)): (e1002310-e1002310). [PMID:22194678] |
| 68. Yangyang Sun, Zhuzhu Tang, Yanjun Li, Yongkang Song, Hualei Wang, Dongzhi Wei, Shengli Yang. (2024) Identification and evolution of non-traditional nitrilase from Spirosoma linguale DSM 74 with high hydration activity. BIOORGANIC CHEMISTRY, 143 (107055). [PMID:38185008] |
| 69. Zhi Chen, Zhaohe Dong, Xin Ju, Lishi Yan, Liangzhi Li, Donzhi Wei. (2023) Screening of a novel and thermostable nicotinate dehydrogenase-producing strain Bacillus paramycoides for efficient synthesis of 6-hydroxynicotinic acid. BIOCATALYSIS AND BIOTRANSFORMATION, [PMID:22383884] |
| 70. Fangfang Li, Yueyue Hu, Yong Cheng, Ying-Hua Zhou. (2024) Design of composite based on UiO-66 and ionic liquid for the CO2 conversion into cyclocarbonate. MICROPOROUS AND MESOPOROUS MATERIALS, 365 (20): (112909). [PMID:20723760] |
| 71. Zhipeng Wang, Tingting Ma, Junkai Wang, Shaorun Zhu, Mei Zhang, Min Guo. (2023) Surface passivation for efficient and stable perovskite solar cells in ambient air: The structural effect of amine molecules. CERAMICS INTERNATIONAL, [PMID:] |
| 72. Xinyu Shao, Lulu Cao, Lixia Lu. (2024) Ultrasensitive detection of glucose oxidase and alkaline phosphatase in milk based on valence regulated upconversion nanoprobes. FOOD CHEMISTRY, 432 (137212). [PMID:37634343] |
| 73. Yu Yangjian, Liu Peng, Wang Fazhou, Hu Chuanlin. (2023) Preparation of Hydrophobic Fly Ash by Surface Modification and Oil-water Separation Devices. JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION, 38 (3): (695-700). [PMID:] |
| 74. Xiao-Dong Cheng, Zheng Zhang, Yun-Ping Li. (2023) A facile approach to undecylenic acid-functionalized stationary phases for per aqueous liquid chromatography. ANALYTICA CHIMICA ACTA, 1265 (341337). [PMID:37230580] |
| 75. Chao-ping He, Wen-juan Quan, Ya-ling Zeng, Hong-yan Zhou, Pei-dong You, Zhen-xian Li, Ya-mei Li, Li-mei Lin, Bin Liu, Duan-fang Liao, Qin-hui Tuo. (2023) Construction of nicotinic acid curcumin nanoparticles and its Anti-atherosclerosis effect via PCSK9/LDL-R, ABCA1/Caveolin-1/LXR pathway. MATERIALS & DESIGN, 229 (111931). [PMID:] |
| 76. Zhiyong Zheng, Yuehua Deng, Weining Xie, Sirui Chen, Xiaoxiao Liang, Shiyuan Liu, Yanbin Jiang, Huaiyu Yang. (2023) Co-Former Screening Method for Multicomponent Crystals Based on Partial Least Squares Regression: A Case Study of Ciprofloxacin. CRYSTAL GROWTH & DESIGN, 23 (5): (3244–3257). [PMID:] |
| 77. Hengye Li, Xingwei Han, Lin Zhang, Wenjie Yu, Wenwen Bie, Meijie Wei, Zhongxia Wang, Fenying Kong, Wei Wang. (2023) Sulfonated polyhedral oligomeric silsesquioxane-cyclodextrin hybrid polymers for efficient removal of micropollutants from water. CARBOHYDRATE POLYMERS, 312 (120832). [PMID:37059548] |
| 78. Wenlong Wan, Jie Xu, Jiayuan Shi, Xin Zhang, Anran Wang, Xiaojing Dong, Shuyan Miao. (2023) The interaction of dietary niacin and lipid affects the growth, antioxidant capacity and lipid metabolism of male Eriocheir sinensis. Aquaculture Reports, 30 (101541). [PMID:] |
| 79. Hengye Li, Xingwei Han, Wenjie Yu, Lin Zhang, Wenwen Bie, Meijie Wei, Zhongxia Wang, Fenying Kong, Wei Wang. (2023) Synthesis of porous dimethoxypillar[5]arene knitted β-cyclodextrin copolymers for efficient adsorption of organic micropollutants. CARBOHYDRATE POLYMERS, 310 (120719). [PMID:36925245] |
| 80. Xue-Jiao Liu, Bao-Di Ma, Xiao-Mei Wu, Yi Xu. (2023) Highly Efficient Biosynthesis of Nicotinic Acid by Immobilized Whole Cells of E. coli Expressing Nitrilase in Semi-Continuous Packed-Bed Bioreactor. Catalysts, 13 (2): (371). [PMID:] |
| 81. Hongwei Ren, Yize Liu, Ruoyao Zhang, Tengda Zhao, Jing Han, Zhiyang Zheng, Erhong Duan. (2023) Investigation of the CO2 capture behavior in multiple-site natural deep eutectic solvents. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, 172 (136). [PMID:] |
| 82. Huifang Wu, Mengqi Xu, Yubing Chen, Haoliang Zhang, Yongjun Shen, Yanfeng Tang. (2022) A Highly Sensitive and Selective Nano-Fluorescent Probe for Ratiometric and Visual Detection of Oxytetracycline Benefiting from Dual Roles of Nitrogen-Doped Carbon Dots. Nanomaterials, 12 (23): (4306). [PMID:36500929] |
| 83. Zhiqin Ding, Mengdie Cai, Weimin Gan, Ping Yuan, Lijun Wei, Xianglei Cheng. (2023) Studies on a novel method for the determination of nitrosamines in food by HPLC-UV-FLD coupling with terbium-doped carbon dots. FOOD CHEMISTRY, 405 (134894). [PMID:] |
| 84. Lin Yuan, Lei Jiang, Ze Liu, Yingying Xiang, Fei Song, Yujiao Tu. (2023) Selective and sensitive simultaneous detection of tartrazine and Hg2+ based on N-doped yellow-green fluorescent carbon dots. DYES AND PIGMENTS, 209 (110893). [PMID:] |
| 85. Jinsong Wang, Farzad Seidi, Yang Huang, Huining Xiao. (2022) Smart lignin-based polyurethane conjugated with corrosion inhibitor as bio-based anticorrosive sublayer coating. INDUSTRIAL CROPS AND PRODUCTS, 188 (115719). [PMID:] |
| 86. Yingying Xiang, Yujiao Tu, Lei Jiang, Lin Yuan, Ze Liu, Qiang Xie, Xuequan Xiong, Fei Song. (2022) Orange fluorescent dual-mode nanoprobe for selective and sensitive detection of amaranth based on S,N-Doped carbon dots. DYES AND PIGMENTS, 205 (110533). [PMID:] |
| 87. Shan Yuan, Miaomiao Jin, Chao Xu, Wencheng Yin, Mingsha Zhao, Mo Xian, Wei Liu. (2022) Self-sufficient whole-cell biocatalysis for 3-(aminomethyl) pyridine synthesis. BIOCHEMICAL ENGINEERING JOURNAL, 183 (108457). [PMID:] |
| 88. Xiang Yingying, Song Fei, Jiang Lei, Liu Ze, Tu Yujiao. (2022) Novel Fluorescent Nano Carbon Quantum Dots Derived From Lactarius Hatsudake for High Selective Vitamin B12 Detection. JOURNAL OF AOAC INTERNATIONAL, 105 (5): (1350-1359). [PMID:35244160] |
| 89. Haizhi Zhang, Hongyuan Wu, Xinguang Qin, Ying Shen, Xinlin Wei, Gang Liu. (2022) Metalloporphyrin and gold nanoparticles modified hollow zeolite imidazole Framework-8 with excellent peroxidase like activity for quick colorimetric determination of choline in infant formula milk powder. FOOD CHEMISTRY, 384 (132552). [PMID:35231712] |
| 90. Zhijun Zhao, Jubao Gao, Mingsheng Luo, Xinyue Liu, Yongsheng Zhao, Weiyang Fei. (2022) Molecular Simulation and Experimental Study on Low-Viscosity Ionic Liquids for High-Efficient Capturing of CO2. ENERGY & FUELS, 36 (3): (1604–1613). [PMID:] |
| 91. Wang Qiaoying, Cai Jiali, Xu Zihan, Huang Shihui, Zhou Ruiping, Wang Zhiyong. (2022) Albumin-based Theranostic Nanosystem for Drug Controlled Release and Magnetic Resonance Imaging Guided Therapy. Journal of Bionic Engineering, 19 (1): (188-196). [PMID:] |
| 92. Mengqi Huang, Changlun Tong. (2022) Silicon nanoparticles / gold nanoparticles composite as a fluorescence probe for sensitive and selective detection of Co2+ and vitamin B12 based on the selective aggregation and inner filter effect. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 268 (120706). [PMID:34915228] |
| 93. Li Qiaofeng, Lan Taijin, He Songhua, Chen Weiwei, Li Xiaolan, Zhang Weiquan, Liu Ying, Zhang Qiuping, Chen Xin, Han Yaoyao, Su Zhiheng, Zhu Dan, Guo Hongwei. (2021) A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model. Chinese Medicine, 16 (1): (1-21). [PMID:34627325] |
| 94. Xiao-Dong Cheng,Yan-Hong Hao,Xi-Tian Peng,Bi-Feng Yuan,Zhi-Guo Shi,Yu-Qi Feng. (2015-05-13) Preparation and chromatographic evaluation of zwitterionic stationary phases with controllable ratio of positively and negatively charged groups.. Talanta, 141 (8-14). [PMID:25966373] |